• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经导管动脉栓塞术后肝细胞癌患者动脉血中酮体比率及丙酮酸和乳酸水平的变化]

[Changes in ketone body ratio and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma after transcatheter arterial embolization].

作者信息

Mizobuchi N, Kuwao F, Takeda I, Takemura T, Morita S, Horimi T, Takahashi I

机构信息

Department of Cancer Institute, Kochi Municipal Central Hospital.

出版信息

Rinsho Byori. 1990 Jul;38(7):825-9.

PMID:2169547
Abstract

The ketone body ratio (acetoacetate/3-hydroxybutyrate:KBR) and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma (HCC) were examined. KBRs and levels of pyruvate and lactate in patients with HCC were similar to those in patients without liver diseases (1.57 +/- 0.88, 0.84 +/- 0.32, 11.4 +/- 4.5 vs 1.80 +/- 0.9, 0.89 +/- 0.48, 10.8 +/- 6.2). However, pyruvate to lactate ratios were significantly lower in HCC patients (7.45 +/- 1.57 vs 8.62 +/- 2.15, p less than 0.05). Among the HCC patients the levels of pyruvate and lactate were significantly higher in patients with liver cirrhosis (LC) than those in patients without LC. The sequential changes of KBRs and levels of pyruvate and lactate were examined before and after transcatheter arterial embolization (TAE). Although KBRs were transiently decreased immediately after TAE, they were at higher levels from the 3rd to 21st day in comparison with those before TAE. The levels of pyruvate and lactate showed no significant changes immediately after TAE. However, they followed a course similar to that of KBRs after TAE. Lower KBRs and higher levels of pyruvate and lactate tended to be observed in HCC patients with LC after TAE than in those without LC. This suggests a decrease of intrahepatic blood flow probably due to histological reconstruction. These results suggest that the presence of LC is one of the most important factors influencing the functional reserve of liver in HCC patients. In HCC patients without LC, the recovery from the overload of TAE may operate at mitochondrial levels at least the 3rd day after TAE.

摘要

检测了肝细胞癌(HCC)患者动脉血中的酮体比率(乙酰乙酸/3-羟基丁酸:KBR)以及丙酮酸和乳酸水平。HCC患者的KBR以及丙酮酸和乳酸水平与无肝脏疾病患者相似(分别为1.57±0.88、0.84±0.32、11.4±4.5与1.80±0.9、0.89±0.48、10.8±6.2)。然而,HCC患者的丙酮酸与乳酸比率显著更低(7.45±1.57与8.62±2.15,p<0.05)。在HCC患者中,肝硬化(LC)患者的丙酮酸和乳酸水平显著高于无LC的患者。在经动脉导管栓塞术(TAE)前后检测了KBR以及丙酮酸和乳酸水平的连续变化。尽管TAE后KBR立即短暂下降,但与TAE前相比,在第3至21天其处于更高水平。TAE后丙酮酸和乳酸水平立即无显著变化。然而,它们在TAE后的变化过程与KBR相似。TAE后,有LC的HCC患者比无LC的患者往往KBR更低,丙酮酸和乳酸水平更高。这提示可能由于组织重建导致肝内血流减少。这些结果表明,LC的存在是影响HCC患者肝脏功能储备的最重要因素之一。在无LC的HCC患者中,至少在TAE后第3天,从TAE负荷中的恢复可能在线粒体水平起作用。

相似文献

1
[Changes in ketone body ratio and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma after transcatheter arterial embolization].[经导管动脉栓塞术后肝细胞癌患者动脉血中酮体比率及丙酮酸和乳酸水平的变化]
Rinsho Byori. 1990 Jul;38(7):825-9.
2
Zinc metabolism after transcatheter arterial embolization for hepatocellular carcinoma.经导管动脉栓塞治疗肝细胞癌后的锌代谢
Hepatogastroenterology. 1998 Jul-Aug;45(22):1082-4.
3
Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization.
Am J Gastroenterol. 1994 Feb;89(2):184-8.
4
[Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].[苯乙烯马来酸新制癌菌素经导管栓塞治疗肝细胞癌——第三次报告]
Gan To Kagaku Ryoho. 2002 Feb;29(2):253-9.
5
Management of spontaneous bleeding due to hepatocellular carcinoma.肝细胞癌所致自发性出血的管理
Minerva Chir. 2002 Jun;57(3):347-56.
6
Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.经导管动脉栓塞术后肝细胞癌破裂:1例罕见病例
Hepatogastroenterology. 1999 Jan-Feb;46(25):453-6.
7
[Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].[部分脾栓塞术(PSE)在经导管动脉栓塞术(TAE)后有胃肠道出血风险的肝细胞癌中的应用价值]
Gan No Rinsho. 1989 May;35(6):690-5.
8
Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.经导管动脉栓塞术和部分肝切除术后血清人肝细胞生长因子水平的变化
Am J Gastroenterol. 1992 Aug;87(8):1014-7.
9
[Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].经导管动脉栓塞术联合肝动脉诱导内源性肿瘤坏死因子治疗肝细胞癌
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2845-8.
10
Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.经导管部分脾动脉栓塞术治疗脾功能亢进患者:作为肝细胞癌和肝硬化辅助治疗的临床评估
Hepatogastroenterology. 1986 Jun;33(3):105-8.

引用本文的文献

1
Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.利用 LC-MS 技术检测丙型肝炎患者的肝细胞癌:生物标志物的发现
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 1;966:154-62. doi: 10.1016/j.jchromb.2014.02.043. Epub 2014 Mar 2.